SCHEMBL7073154

SCHEMBL7073154

CC(C)c1cc(Oc2c(Cl)cc(CI)cc2Cl)ccc1O

nearest known ligand 0.71

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
THRB P10828 16/20 0.71
THRA P10827 14/20 0.71
RORC P51449 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL283238 0.88 THRB (0.73) THRBTHRARORC
SCHEMBL282204 0.86 THRB (0.71) THRBTHRARORC
SCHEMBL13662422 0.85 THRB (0.70) THRBTHRARORC
SCHEMBL7069926 0.84 THRA (0.71) THRBTHRA
SCHEMBL7073075 0.83 THRB (0.67) THRBTHRARORC
SCHEMBL13946884 0.83 THRB (0.67) THRBTHRARORC
SCHEMBL19057792 0.83 THRB (0.82) THRBTHRARORC
SCHEMBL29373235 0.83 THRA (1.00) THRBTHRA
SCHEMBL282382 0.83 THRA (1.00) THRBTHRA
SCHEMBL25773015 0.83 THRB (0.71) THRBTHRARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000008-B1 NOVEL THYROID RECEPTOR LIGANDS AND METHOD KAROBIO AB (SE) 2003-06-25 EP claimed
US-6465687-B1 SUBSTITUTED 4-HYDROXY-3-ALKYL- OR CYCLOALKYL-PHENOXYBENZENE COMPOUNDS SUCH AS 3,5-DIBROMO-4-(4-HYDROXY-3-ISOPROPYLPHENOXY)BENZOIC ACID, EXPRESSION INHIBITION OF A T3 REGULATED GENE KARO BIO AB (SE) 2002-10-15 US claimed
EP-1000008-B1 NOVEL THYROID RECEPTOR LIGANDS AND METHOD KAROBIO AB (SE) 2003-06-25 EP disclosed
US-6465687-B1 SUBSTITUTED 4-HYDROXY-3-ALKYL- OR CYCLOALKYL-PHENOXYBENZENE COMPOUNDS SUCH AS 3,5-DIBROMO-4-(4-HYDROXY-3-ISOPROPYLPHENOXY)BENZOIC ACID, EXPRESSION INHIBITION OF A T3 REGULATED GENE KARO BIO AB (SE) 2002-10-15 US disclosed